Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.
Ontology highlight
ABSTRACT: Sustained antiviral responses of chronic hepatitis C virus (HCV) infection have improved recently by the use of direct-acting antiviral agents along with interferon (IFN)-α and ribavirin. However, the emergence of drug-resistant variants is expected to be a major problem. We describe here a novel combinatorial small interfering RNA (siRNA) nanosome-based antiviral approach to clear HCV infection. Multiple siRNAs targeted to the highly conserved 5'-untranslated region (UTR) of the HCV genome were synthesized and encapsulated into lipid nanoparticles called nanosomes. We show that siRNA can be repeatedly delivered to 100% of cells in culture using nanosomes without toxicity. Six siRNAs dramatically reduced HCV replication in both the replicon and infectious cell culture model. Repeated treat
SUBMITTER: Chandra PK
PROVIDER: S-EPMC3437587 | biostudies-literature | 2012 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA